What is Imperagen?
Imperagen is a biotechnology research company specializing in AI-driven enzyme engineering solutions tailored for industrial and life science applications. Operating as a deep tech platform, Imperagen integrates machine learning, quantum physics simulations, and automated laboratory systems to design and optimize enzymes. The company's core focus is on accelerating biocatalyst development across pharmaceuticals, chemicals, and sustainable manufacturing sectors. This is achieved through a closed-loop experimentation process and data-driven model refinement, positioning Imperagen at the forefront of innovation in enzyme technology.
How much funding has Imperagen raised?
Imperagen has raised a total of $11M across 1 funding round:
Seed
$11M
Seed (2026): $11M with participation from Northern Gritstone and IQ Capital
Key Investors in Imperagen
Northern Gritstone
Northern Gritstone is an investment company dedicated to supporting science and technology businesses in the North of England, founded by the Universities of Manchester, Leeds, and Sheffield. Their philosophy combines profit with purpose, aiming for strong investor returns and positive societal impacts, including high-skilled job creation.
IQ Capital
IQ Capital is a venture capital firm based in Cambridge and London, managing £300m in assets. They invest in 'deep-tech' across sectors like machine learning, AI, robotics, advanced engineering, materials, and data-focused propositions. IQ Capital typically makes initial investments ranging from £300k to £5m, with capacity for follow-on investment up to £30m, and has a track record of over 20 exits to companies including Oracle, Google, Apple, Huawei, and Facebook.
What's next for Imperagen?
The recent major strategic investment signals a pivotal phase for Imperagen, likely enabling the company to scale its operations, expand its research and development capabilities, and further commercialize its AI-driven enzyme engineering platform. This capital infusion is expected to accelerate the development of novel biocatalysts for critical industries, reinforcing Imperagen's position in the deep tech and biotechnology landscape. The company's focus on sustainable manufacturing and pharmaceutical applications suggests a strategic expansion into high-impact markets.
See full Imperagen company page
